Thierry Chauche's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 88,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 44,000 | 59,688 | - | 0 | Series A Common Stock | |
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.36 per share. | 10 Feb 2026 | 1,312 | 15,688 | - | 5.4 | 7,033 | Series A Common Stock |
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 69,000 | 69,000 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 17,000 | 17,000 | - | 0 | Series A Common Stock | |
| Sagimet Biosciences Inc (Class A) | Thierry Chauche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 587,181 | 587,181 | - | - | Stock Option (Right to Buy) |